bluuebunny/crossref_metadata_2025 huggingface dataset:
Human rights and climate wrongs: Mapping the landscape of rights‐based climate litigation
Authors: Iyengar Shalini
Published: March 2023

Human rights‐based climate litigation cases have become increasingly prominent over the past decade. While absolute numbers of these cases are still relatively low, they have attracted significant praise and scrutiny, both from the standpoint of the media and the academy. However, while there is a large body of scholarly literature on these rights‐based climate cases, relatively little qualitative research has focused on the actors bringing these claims before the court. This article uses qualitative socio‐legal research methods to examine how lawyers and activists in the climate litigation space think about these cases, their strategies and their reasons for using human rights‐based arguments to address the climate crisis. By foregrounding these actors and their voices, this article tells the story of the human rights‐based climate litigation movement and how it came together.
Differential Flatness of Slider–Pusher Systems for Constrained Time Optimal Collision Free Path Planning
Authors: Lefebvre Tom , De Witte Sander , Neve Thomas , Crevecoeur Guillaume
Published: March 2023

In this work, we show that the differential kinematics of slider–pusher systems are differentially flat assuming quasi-static behavior and frictionless contact. Second, we demonstrate that the state trajectories are invariant to time-differential transformations of the path parametrizing coordinate. For one this property allows to impose arbitrary velocity profiles on the slider without impacting the geometry of the state trajectory. This property implies that certain path planning problems may be decomposed approximately into a strictly geometric path planning and an auxiliary throughput speed optimization problem. Building on these insights, we elaborate a numerical approach tailored to constrained time optimal collision free path planning and apply it to the slider–pusher system.
Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study
Authors: Foo Damien , Sarna Mohinder , Pereira Gavin , Moore Hannah C , Regan Annette K
Published: March 2023

Objective

To assess the association betweenin uteroexposure to seasonal inactivated influenza vaccine (IIV) and the risk of a diagnosis of a neurodevelopmental disorder in early childhood.

Design

Retrospective cohort study.

Setting

Population-based birth registry linked with health administrative databases in Western Australia (WA).

Participants

Singleton, liveborn children born between 1 April 2012 and 1 July 2016 in WA.

Exposure

Receipt of seasonal IIV during pregnancy obtained from a state-wide antenatal vaccination database.

Main outcome measures

Clinical diagnosis of a neurodevelopmental disorder was recorded from hospital inpatient and emergency department records. We used Cox proportional hazard regression, weighted by the inverse-probability of treatment (vaccination), to estimate the hazard ratio (HR) of neurodevelopmental disorders associated within uteroexposure to seasonal IIV.

Results

The study included 140 514 children of whom, 15 663 (11.2%) were exposed to seasonal IIVin utero. The prevalence of neurodevelopmental disorders was 5.4%, including mental or behavioural (0.4%), neurological (5.1%), seizure (2.2%) and sleep disorders (2.7%). Maternal IIV was not associated with increased risk of neurodevelopmental disorders (HR 1.00; 95% CI 0.91 to 1.08). Children exposed in the first trimester had a lower risk of seizure disorders (adjusted HR [aHR] 0.73; 95% CI 0.54 to 0.998), and preterm children exposed any time during pregnancy had a lower risk of sleep disorders (aHR 0.63; 95% CI 0.41 to 0.98).

Conclusions

We did not observe increased risk of neurodevelopmental disorders followingin uteroexposure to seasonal IIV. Although we observed some evidence for lower risk of seizure and sleep disorders, additional studies are required to confirm.
Injury acknowledgement by reduction of sports load in world-leading athletics (track and field) athletes varies with their musculoskeletal health literacy and the socioeconomic environment
Authors: Timpka Toomas , Fagher Kristina , Bargoria Victor , Andersson Christer , Jacobsson Jenny , Gauffin Håkan , Hansson Per-Olof , Adami Paolo Emilio , Bermon Stéphane , Dahlström Örjan
Published: March 2023

Objective

Although injury burden prompts elite athletics (track and field) athletes to engage in injury management, little is known about their health literacy. We investigated musculoskeletal (MS) health literacy in world-leading athletics athletes and associations with prechampionship injury acknowledgement by reduction of training load in different socioeconomic environments.

Methods

Adult and youth athletics athletes (n=1785) preparing for World Championships were invited to complete the Literacy in Musculoskeletal Problems instrument and report acknowledgement of injury by reduction in training load during prechampionship tapering. Their socioeconomic standing was estimated through the Human Development Index of their home country. Demographic differences were examined using χ2tests and determinants of injury acknowledgement assessed using logistic regression.

Results

Complete data were obtained from 780 athletes (43.7%) with 26% demonstrating sufficient MS health literacy, higher in adult (41%) than youth (13%) athletes (p<0.001). Adult athletes at the uppermost socioeconomic level showed higher MS health literacy than athletes at lower socioeconomic levels (p<0.001). At the uppermost socioeconomic level, adult athletes with sufficient MS health literacy had increased likelihood of acknowledging an injury by reduction in training load compared with peers demonstrating insufficient MS health literacy (OR=2.45; 95% CI 1.33–4.53). Athletes at middle socioeconomic levels with sufficient MS health literacy had decreased likelihood for acknowledging an injury during tapering (OR=0.29; 95% CI 0.11–0.78).

Conclusions

The prevalence of sufficient MS health literacy in world-leading athletics athletes is low. Associations between MS health literacy and injury acknowledgement in these athletes vary with the resourcefulness of the socioeconomic environment, implying that health literacy and resources for medical and performance support should be ascertained concurrently.
Role of patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain: a comprehensive narrative review
Authors: Shanthanna Harsha , Eldabe Sam , Provenzano David Anthony , Chang Yaping , Adams Daniel , Kashir Imad , Goel Akash , Tian Chenchen , Couban Rachel J , Levit Tal , Hagedorn Jonathan M , Narouze Samer
Published: March 2023

Background/importance

Patient selection for spinal cord stimulation (SCS) therapy is crucial and is traditionally performed with clinical selection followed by a screening trial. The factors influencing patient selection and the importance of trialing have not been systematically evaluated.

Objective

We report a narrative review conducted to synthesize evidence regarding patient selection and the role of SCS trials.

Evidence review

Medline, EMBASE and Cochrane databases were searched for reports (any design) of SCS in adult patients, from their inception until March 30, 2022. Study selection and data extraction were carried out using DistillerSR. Data were organized into tables and narrative summaries, categorized by study design. Importance of patient variables and trialing was considered by looking at their influence on the long-term therapy success.

Findings

Among 7321 citations, 201 reports consisting of 60 systematic reviews, 36 randomized controlled trials (RCTs), 41 observational studies (OSs), 51 registry-based reports, and 13 case reports on complications during trialing were included. Based on RCTs and OSs, the median trial success rate was 72% and 82%, and therapy success was 65% and 61% at 12 months, respectively. Although several psychological and non-psychological determinants have been investigated, studies do not report a consistent approach to patient selection. Among psychological factors, untreated depression was associated with poor long-term outcomes, but the effect of others was inconsistent. Most RCTs except for chronic angina involved trialing and only one RCT compared patient selection with or without trial. The median (range) trial duration was 10 (0–30) and 7 (0–56) days among RCTs and OSs, respectively.

Conclusions

Due to lack of a consistent approach to identify responders for SCS therapy, trialing complements patient selection to exclude patients who do not find the therapy helpful and/or intolerant of the SCS system. However, more rigorous and large studies are necessary to better evaluate its role.
Mechanism and Molecular Targets of a Water-Soluble Extract of Artemisia annua on the Treatment of Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation
Authors: Zhou Wen-Shu , Silva Marta , Yang Chao , Li Shuai , Chen Yi-Tian , Zheng Wen-Hua
Published: March 2023

Oxidative stress is an important contributor to the pathogenesis of Alzheimer’s disease (AD). The overproduction of reactive oxygen species observed in AD patients results in the loss of mitochondrial function, altered metal ion homeostasis, lipopolysaccharide metabolism disorder, reduced anti-oxidant defense, increased release of inflammatory factors, and the aggravation and accumulation of amyloid-beta and tau hyper-phosphorylation, which directly cause synaptic and neuronal loss and lead to cognitive dysfunction. Thus, oxidative stress proves to be a fundamental part of AD development and progression, suggesting the potential benefits of anti-oxidant-based therapies for AD. In this study, we found that a water-soluble extract of Artemisia annua (WSEAA), a traditional Chinese herbal medicine, has a strong anti-oxidant function. We also found that WSEAA is able to improve the cognitive function of 3xTg AD mice. However, the mechanisms and molecular targets underlying WSEAA action are still not known. In order to uncover the potential molecular mechanisms involved, we used a combination of network pharmacology and different experimental approaches. Obtained results revealed key genes (such as AKT1, BCL2, IL-6, TNF-[Formula: see text] and BAX) and signaling pathways (like PI3K-AKT and BCL2/BAX) are closely associated with the biological processes responding to oxidative stress. Further verification of the survival/anti-oxidant effects of WSEAA in vitro and in vivo showed that the extract has anti-oxidatant/neuronal survival action against H2O2-induced damage, and is thus able to prevent the cognitive decline and pathological changes of 3xTg transgenic (3xTg) mice via the regulation of key target-genes and pathways, such as PI3K-AKT and BCL2/BAX, related to survival/apoptosis. Our findings strongly indicate the potential of WSEAA for the prevention and treatment of AD.
A Modal Derivatives Enhanced Kron’s Substructuring Method to Calculate Structural Responses and Response Sensitivities of Geometrically Nonlinear Systems
Authors: Tian Wei , Weng Shun , Xia Yong
Published: March 2023

This paper develops a modal derivative enhanced Kron’s substructuring method to calculate the structural responses and response sensitivities of geometrically nonlinear systems. The proposed method divides the global structure into substructures, which are then assembled in a dual form. The substructural displacements are approximated around the initial linear equilibrium position by using a quadratic modal manifold governed by a few master modes only. A time-variant reduction basis augmented by the master modal derivatives is derived from the quadratic modal manifold, enabling the geometric nonlinearities to be accurately captured. With the reduction basis, the global system is transformed into a reduced one containing the master modes only. Subsequently, the master modal responses and response sensitivities are solved efficiently from the reduced system. The global structural responses and response sensitivities are finally recovered from the master modal solutions based on the quadratic modal manifold. The effectiveness of the proposed method is demonstrated through its application to a thin plate structure. The reduced system enjoys the merit of Kron’s substructuring method that does not contain the interface degrees of freedom. Besides, the proposed reduced system is formed from the quadratic modal manifold directly. Its size is equal to the number of master modes of the substructures and smaller than that of the conventional method, where its size grows quadratically with the number of master modes.
MUSCLE RUB ENHANCED EXPLOSIVE LEG POWER BUT NOT FLEXIBILITY OR BALANCE IN COLLEGE ATHLETES
Authors: CHIAM MELODY J. , KONG PUI W.
Published: March 2023

Athletes often use muscle rub to heat up the muscles during warm-up as they believe this will improve their sports performance. However, there is no clear evidence on whether muscle rub application to the upper legs can improve physical performance in athletes. Twenty college athletes were randomized to either receiving 3[Formula: see text]g of muscle rub or a placebo. Static flexibility, dynamic balance, and explosive leg power were measured before and after the application of the muscle rub/placebo. Percentage changes in the performance scores (post–pre) were calculated and compared between the muscle rub and placebo groups using the Mann–Whitney U test and the smallest worthwhile change was calculated to offer further insights for individual participants. Results showed that jump distance significantly increased by 1.7% ([Formula: see text], large effect size) with muscle rub application compared to placebo. There was no significant difference in the percentage change between muscle rub and placebo groups in flexibility ([Formula: see text]) and dynamic balance ([Formula: see text]) performances. In conclusion, application of muscle rub on the upper legs positively enhanced explosive leg power but did not affect flexibility or dynamic balance performances.
On Control on Integral Characteristics of Transport of a Medicinal Product in an Organism
Authors: Pankratov E. L.
Published: March 2023

In this paper, we introduce a model of transport of a medicinal product in an organism. The model is based on estimation of integral characteristics. We introduce an analytical approach for analysis of the considered transport with account of changing conditions. We consider a possibility to accelerate and decelerate transport of the above medicinal product.
Review Paper on Beach Evolution of the Indian Coasts
Authors: Mohanty Shravani , Kumar Rajendra
Published: March 2023

Beaches provide protection to residents living near the ocean by acting as a buffer against the high winds and waves of powerful storms or rough seas. It also helps the government to increase revenue and the development of infrastructure. Because beaches are very accessible to humans, it is very important to go through the demerits that are causing changes in the beaches and what steps can be taken to prevent the beaches from evolving. There are several studies indicating that there is an increase in the wave heights and wave periods along the Indian coasts, with maximum wave heights increasing by more than 30% in some of the locations. It is also found that at most of the locations along the east coast, wave periods are expected to increase by almost 20% whereas along the west coast, they are expected to increase by around 10% [ Chowdhury et al. [ 2019 ] “Wave climate projections along the Indian coast,” Int. J. Climatol. https://doi.org/10.1002/joc.6096 .]. This will alter the distribution of wave energy at the shoreline, swash-aligned beaches and additionally the design of coastal structures. It is particularly important to evaluate the wave characteristics and sediment transport which leads to erosion and/or siltation problems along the Indian coasts. In this paper, an extensive review on wave hydrodynamics, sediment transport and coastal erosion is compiled along the Indian coasts.
NSFuzz: Towards Efficient and State-Aware Network Service Fuzzing
Authors: Qin Shisong , Hu Fan , Ma Zheyu , Zhao Bodong , Yin Tingting , Zhang Chao
Published: March 2023

As an essential component responsible for communication, network services are security critical, thus, it is vital to find their vulnerabilities. Fuzzing is currently one of the most popular software vulnerability discovery techniques, widely adopted due to its high efficiency and low false positives. However, existing coverage-guided fuzzers mainly aim at stateless local applications, leaving stateful network services underexplored. Recently, some fuzzers targeting network services have been proposed but have certain limitations, for example, insufficient or inaccurate state representation and low testing efficiency.

In this article, we propose a new fuzzing solution NSFuzz for stateful network services. We studied typical implementations of network service programs to determine how they represent states and interact with clients. Accordingly, we propose (1) a program variable–based state representation scheme and (2) an efficient interaction synchronization mechanism to improve fuzzing efficiency. We implemented a prototype of NSFuzz, which uses static analysis and annotation application programming interfaces (APIs) to identify synchronization points and state variables within the services. It then achieves fast I/O synchronization and accurate service state tracing to carry out efficient state-aware fuzzing via lightweight compile-time instrumentation. The evaluation results show that compared with other network service fuzzers, including AFL
net
and S
tate
AFL, our solution NSFuzz could infer a more accurate state model during fuzzing and improve fuzzing throughput by up to 200×. In addition, NSFuzz could improve code coverage by up to 25% and trigger more crashes in less time. We also performed a fuzzing campaign to find new bugs in the latest version of the target services; 8 zero-day vulnerabilities have been found by NSFuzz.
Antibody-Based Electrochemical Sensor for Detection of the Full-Length Phosphorylated TDP-43 Protein Biomarker of Amyotrophic Lateral Sclerosis
Authors: Wallace William , Tabobondung Meaghan , Esposto Josephine , Martic Sanela
Published: March 2023

Transactive response DNA binding protein (TDP-43) is a biomarker associated with neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS). ALS remains without treatment or a cure, and diagnosis relies on the onset of symptoms. Hence, novel methods are needed for the early detection of TDP-43 as an ALS biomarker. Toward this aim, the detection of full-length phosphorylated TDP-43 (pTDP-43) was achieved by using the electrochemical impedance spectroscopy (EIS)-based biosensor. The TDP-43 antibodies (Abs) on gold (Au) surfaces (Ab-Au) were employed as recognition probes for the protein detection. EIS was used to characterize the Ab-Au surface before and after pTDP-43 binding. In the presence of a solution redox probe, [Fe(CN)6]3−/4−, the dramatic changes in the charge-transfer resistance (Rct) values were observed after the pTDP-43 binding and were directly related to the amount of protein present in solution. Sensitivity for pTDP-43 was highly dependent on the antibody used as a recognition probe, and the pTDP-43 was detected at the limit of detection of 11 ± 6 nM with a large dynamic range, and excellent selectivity against the common bovine serum albumin. This study provides the example of a methodology for fabricating an immunosensor as a recognition layer for ALS protein which can be easily extended for the detection of other disease-related biomarkers.
Supplementary Figure 1 from Phosphoinositide 3-kinase/AKT Signaling Can Promote AIB1 Stability Independently of GSK3 Phosphorylation
Authors: Ferrero Macarena , Avivar Álvaro , García-Macías María Carmen , de Mora Jaime Font
Published: March 2023

Supplementary Figure 1 from Phosphoinositide 3-kinase/AKT Signaling Can Promote AIB1 Stability Independently of GSK3 Phosphorylation
Supplementary Figure 2 from The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
Authors: Hatton Beryl A. , Villavicencio Elisabeth H. , Tsuchiya Karen D. , Pritchard Joel I. , Ditzler Sally , Pullar Barbara , Hansen Stacey , Knoblaugh Sue E. , Lee Donghoon , Eberhart Charles G. , Hallahan Andrew R. , Olson James M.
Published: March 2023

Supplementary Figure 2 from The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
Supplementary Figures 1-2 from Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Authors: de la Luz Garcia-Hernandez Maria , Gray Andrew , Hubby Bolyn , Klinger Otto J. , Kast W. Martin
Published: March 2023

Supplementary Figures 1-2 from Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Supplementary Figure Legends 1-2 from Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Authors: de la Luz Garcia-Hernandez Maria , Gray Andrew , Hubby Bolyn , Klinger Otto J. , Kast W. Martin
Published: March 2023

Supplementary Figure Legends 1-2 from Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity
Supplementary Table 2 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
Authors: Ouillette Peter , Erba Harry , Kujawski Lisa , Kaminski Mark , Shedden Kerby , Malek Sami N.
Published: March 2023

Supplementary Table 2 from Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
Supplementary Figure 9 from Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas
Authors: Becher Oren J. , Hambardzumyan Dolores , Fomchenko Elena I. , Momota Hiroyuki , Mainwaring Lori , Bleau Anne-Marie , Katz Amanda M. , Edgar Mark , Kenney Anna M. , Cordon-Cardo Carlos , Blasberg Ron G. , Holland Eric C.
Published: March 2023

Supplementary Figure 9 from Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas
Supplementary Figure 7 from Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas
Authors: Becher Oren J. , Hambardzumyan Dolores , Fomchenko Elena I. , Momota Hiroyuki , Mainwaring Lori , Bleau Anne-Marie , Katz Amanda M. , Edgar Mark , Kenney Anna M. , Cordon-Cardo Carlos , Blasberg Ron G. , Holland Eric C.
Published: March 2023

Supplementary Figure 7 from Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas
Supplementary Figure 1 from Peroxisome Proliferator-Activated Receptor-δ Induces Cell Proliferation by a Cyclin E1–Dependent Mechanism and Is Up-regulated in Thyroid Tumors
Authors: Zeng Lingchun , Geng Yan , Tretiakova Maria , Yu Xuemei , Sicinski Peter , Kroll Todd G.
Published: March 2023

Supplementary Figure 1 from Peroxisome Proliferator-Activated Receptor-δ Induces Cell Proliferation by a Cyclin E1–Dependent Mechanism and Is Up-regulated in Thyroid Tumors
Supplementary Table 1, Figures 1-3 from LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic Proteins
Authors: Zhong Diansheng , Liu Xiuju , Khuri Fadlo R. , Sun Shi-Yong , Vertino Paula M. , Zhou Wei
Published: March 2023

Supplementary Table 1, Figures 1-3 from LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic Proteins
Supplementary Figure 2 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
Authors: Harris Molly A. , Yang Hyuna , Low Benjamin E. , Mukherje Joydeep , Guha Abhijit , Bronson Roderick T. , Shultz Leonard D. , Israel Mark A. , Yun Kyuson
Published: March 2023

Supplementary Figure 2 from Cancer Stem Cells Are Enriched in the Side Population Cells in a Mouse Model of Glioma
Supplementary Table 3 from MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer
Authors: Findlay Victoria J. , Turner David P. , Moussa Omar , Watson Dennis K.
Published: March 2023

Supplementary Table 3 from MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer
Supplementary Figure 1 Legend from MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer
Authors: Findlay Victoria J. , Turner David P. , Moussa Omar , Watson Dennis K.
Published: March 2023

Supplementary Figure 1 Legend from MicroRNA-Mediated Inhibition of Prostate-Derived Ets Factor Messenger RNA Translation Affects Prostate-Derived Ets Factor Regulatory Networks in Human Breast Cancer
Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Authors: Oda Katsutoshi , Okada Jennifer , Timmerman Luika , Rodriguez-Viciana Pablo , Stokoe David , Shoji Keiko , Taketani Yuji , Kuramoto Hiroyuki , Knight Zachary A. , Shokat Kevan M. , McCormick Frank
Published: March 2023

Supplementary Figure 6 from PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation
Supplementary Methods and Figure Legends 1-5 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Authors: Taniguchi Hiroya , Yoshida Tatsushi , Horinaka Mano , Yasuda Takashi , Goda Ahmed E. , Konishi Masako , Wakada Miki , Kataoka Keisho , Yoshikawa Toshikazu , Sakai Toshiyuki
Published: March 2023

Supplementary Methods and Figure Legends 1-5 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Supplementary Figure 3 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Authors: Taniguchi Hiroya , Yoshida Tatsushi , Horinaka Mano , Yasuda Takashi , Goda Ahmed E. , Konishi Masako , Wakada Miki , Kataoka Keisho , Yoshikawa Toshikazu , Sakai Toshiyuki
Published: March 2023

Supplementary Figure 3 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Supplementary Figure 1 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Authors: Taniguchi Hiroya , Yoshida Tatsushi , Horinaka Mano , Yasuda Takashi , Goda Ahmed E. , Konishi Masako , Wakada Miki , Kataoka Keisho , Yoshikawa Toshikazu , Sakai Toshiyuki
Published: March 2023

Supplementary Figure 1 from Baicalein Overcomes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells
Supplementary Tables 2-14 from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Authors: Ren Yue-Xin , Finckenstein Friedrich Graf , Abdueva Diana A. , Shahbazian Violette , Chung Brile , Weinberg Kenneth I. , Triche Timothy J. , Shimada Hiroyuki , Anderson Michael J.
Published: March 2023

Supplementary Tables 2-14 from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Supplementary Table 8 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Authors: Hoque Mohammad Obaidul , Kim Myoung Sook , Ostrow Kimberly Laskie , Liu Junwei , Wisman G. Bea A. , Park Hannah Lui , Poeta Maria Luana , Jeronimo Carmen , Henrique Rui , Lendvai Ágnes , Schuuring Ed , Begum Shahnaz , Rosenbaum Eli , Ongenaert Maté , Yamashita Keishi , Califano Joseph , Westra William , van der Zee Ate G.J. , Criekinge Wim Van , Sidransky David
Published: March 2023

Supplementary Table 8 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Supplementary Table 7 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Authors: Hoque Mohammad Obaidul , Kim Myoung Sook , Ostrow Kimberly Laskie , Liu Junwei , Wisman G. Bea A. , Park Hannah Lui , Poeta Maria Luana , Jeronimo Carmen , Henrique Rui , Lendvai Ágnes , Schuuring Ed , Begum Shahnaz , Rosenbaum Eli , Ongenaert Maté , Yamashita Keishi , Califano Joseph , Westra William , van der Zee Ate G.J. , Criekinge Wim Van , Sidransky David
Published: March 2023

Supplementary Table 7 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Supplementary Methods and Materials from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Authors: Ren Yue-Xin , Finckenstein Friedrich Graf , Abdueva Diana A. , Shahbazian Violette , Chung Brile , Weinberg Kenneth I. , Triche Timothy J. , Shimada Hiroyuki , Anderson Michael J.
Published: March 2023

Supplementary Methods and Materials from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Supplementary Table 6 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Authors: Hoque Mohammad Obaidul , Kim Myoung Sook , Ostrow Kimberly Laskie , Liu Junwei , Wisman G. Bea A. , Park Hannah Lui , Poeta Maria Luana , Jeronimo Carmen , Henrique Rui , Lendvai Ágnes , Schuuring Ed , Begum Shahnaz , Rosenbaum Eli , Ongenaert Maté , Yamashita Keishi , Califano Joseph , Westra William , van der Zee Ate G.J. , Criekinge Wim Van , Sidransky David
Published: March 2023

Supplementary Table 6 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Supplementary Table 5 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Authors: Hoque Mohammad Obaidul , Kim Myoung Sook , Ostrow Kimberly Laskie , Liu Junwei , Wisman G. Bea A. , Park Hannah Lui , Poeta Maria Luana , Jeronimo Carmen , Henrique Rui , Lendvai Ágnes , Schuuring Ed , Begum Shahnaz , Rosenbaum Eli , Ongenaert Maté , Yamashita Keishi , Califano Joseph , Westra William , van der Zee Ate G.J. , Criekinge Wim Van , Sidransky David
Published: March 2023

Supplementary Table 5 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Supplementary Figure 2 from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Authors: Ren Yue-Xin , Finckenstein Friedrich Graf , Abdueva Diana A. , Shahbazian Violette , Chung Brile , Weinberg Kenneth I. , Triche Timothy J. , Shimada Hiroyuki , Anderson Michael J.
Published: March 2023

Supplementary Figure 2 from Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Supplementary Table 3 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Authors: Hoque Mohammad Obaidul , Kim Myoung Sook , Ostrow Kimberly Laskie , Liu Junwei , Wisman G. Bea A. , Park Hannah Lui , Poeta Maria Luana , Jeronimo Carmen , Henrique Rui , Lendvai Ágnes , Schuuring Ed , Begum Shahnaz , Rosenbaum Eli , Ongenaert Maté , Yamashita Keishi , Califano Joseph , Westra William , van der Zee Ate G.J. , Criekinge Wim Van , Sidransky David
Published: March 2023

Supplementary Table 3 from Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
Supplementary Figure 3 from Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
Authors: Vogler Meike , Walczak Henning , Stadel Dominic , Haas Tobias L. , Genze Felicitas , Jovanovic Marjana , Gschwend Jürgen E. , Simmet Thomas , Debatin Klaus-Michael , Fulda Simone
Published: March 2023

Supplementary Figure 3 from Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
Supplementary Figures 1-4, Methods and Materials from DNA Methyltransferase 1 and 3B Activate BAG-1 Expression via Recruitment of CTCFL/BORIS and Modulation of Promoter Histone Methylation
Authors: Sun Lunching , Huang Lei , Nguyen Phuongmai , Bisht Kheem S. , Bar-Sela Gil , Ho Allen S. , Bradbury C. Matthew , Yu Wenqiang , Cui Hengmi , Lee Sunmin , Trepel Jane B. , Feinberg Andrew P. , Gius David
Published: March 2023

Supplementary Figures 1-4, Methods and Materials from DNA Methyltransferase 1 and 3B Activate BAG-1 Expression via Recruitment of CTCFL/BORIS and Modulation of Promoter Histone Methylation
Supplementary Table 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Authors: Eichhorn Pieter J.A. , Gili Magüi , Scaltriti Maurizio , Serra Violeta , Guzman Marta , Nijkamp Wouter , Beijersbergen Roderick L. , Valero Vanesa , Seoane Joan , Bernards René , Baselga José
Published: March 2023

Supplementary Table 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Supplementary Figure 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Authors: Eichhorn Pieter J.A. , Gili Magüi , Scaltriti Maurizio , Serra Violeta , Guzman Marta , Nijkamp Wouter , Beijersbergen Roderick L. , Valero Vanesa , Seoane Joan , Bernards René , Baselga José
Published: March 2023

Supplementary Figure 2 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Supplementary Figure 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Authors: Eichhorn Pieter J.A. , Gili Magüi , Scaltriti Maurizio , Serra Violeta , Guzman Marta , Nijkamp Wouter , Beijersbergen Roderick L. , Valero Vanesa , Seoane Joan , Bernards René , Baselga José
Published: March 2023

Supplementary Figure 1 from Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Supplementary Companion Paper from Quantitative Spatiotemporal Analysis of Antibody Fragment Diffusion and Endocytic Consumption in Tumor Spheroids
Authors: Thurber Greg M. , Wittrup K. Dane
Published: March 2023

Supplementary Companion Paper from Quantitative Spatiotemporal Analysis of Antibody Fragment Diffusion and Endocytic Consumption in Tumor Spheroids
Supplementary Table 2 from Levels of SCS7/FA2H-Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734
Authors: Herrero Ana B. , Astudillo Alma M. , Balboa María A. , Cuevas Carmen , Balsinde Jesús , Moreno Sergio
Published: March 2023

Supplementary Table 2 from Levels of SCS7/FA2H-Mediated Fatty Acid 2-Hydroxylation Determine the Sensitivity of Cells to Antitumor PM02734
Supplementary Table 3 from LRRC3B, Encoding a Leucine-Rich Repeat-Containing Protein, Is a Putative Tumor Suppressor Gene in Gastric Cancer
Authors: Kim Mirang , Kim Jeong-Hwan , Jang Hay-Ran , Kim Hwan-Mook , Lee Chang-Woo , Noh Seung-Moo , Song Kyu-Sang , Cho June-Sik , Jeong Hyun-Yong , Hahn Yoonsoo , Yeom Young-Il , Yoo Hyang-Sook , Kim Yong Sung
Published: March 2023

Supplementary Table 3 from LRRC3B, Encoding a Leucine-Rich Repeat-Containing Protein, Is a Putative Tumor Suppressor Gene in Gastric Cancer
Supplementary Figure 3 from Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer
Authors: Geismann Claudia , Morscheck Mascha , Koch Dorothee , Bergmann Frank , Ungefroren Hendrik , Arlt Alexander , Tsao Ming-Sound , Bachem Max G. , Altevogt Peter , Sipos Bence , Fölsch Ulrich R. , Schäfer Heiner , Müerköster Susanne Sebens
Published: March 2023

Supplementary Figure 3 from Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer
Supplementary Figure 3 from Direct Presentation of a Melanocyte-Associated Antigen in Peripheral Lymph Nodes Induces Cytotoxic CD8+ T Cells
Authors: Schuler Prisca , Contassot Emmanuel , Irla Magali , Hugues Stéphanie , Preynat-Seauve Olivier , Beermann Friederich , Donda Alena , French L.E. , Huard Bertrand
Published: March 2023

Supplementary Figure 3 from Direct Presentation of a Melanocyte-Associated Antigen in Peripheral Lymph Nodes Induces Cytotoxic CD8+ T Cells
Supplementary Table 4 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
Authors: Vermeer Maarten H. , van Doorn Remco , Dijkman Remco , Mao Xin , Whittaker Sean , van Voorst Vader Pieter C. , Gerritsen Marie-Jeanne P. , Geerts Marie-Louise , Gellrich Sylke , Söderberg Ola , Leuchowius Karl-Johan , Landegren Ulf , Out-Luiting Jacoba J. , Knijnenburg Jeroen , IJszenga Marije , Szuhai Karoly , Willemze Rein , Tensen Cornelis P.
Published: March 2023

Supplementary Table 4 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
Supplementary Figure Legend from MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
Authors: Bafna Sangeeta , Singh Ajay P. , Moniaux Nicolas , Eudy James D. , Meza Jane L. , Batra Surinder K.
Published: March 2023

Supplementary Figure Legend from MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
Supplementary Data from Early Therapy Evaluation of Combined Anti–Death Receptor 5 Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts by Diffusion-Weighted Magnetic Resonance Imaging
Authors: Kim Hyunki , Morgan Desiree E. , Buchsbaum Donald J. , Zeng Huadong , Grizzle William E. , Warram Jason M. , Stockard Cecil R. , McNally Lacey R. , Long Joshua W. , Sellers Jeffrey C. , Forero Andres , Zinn Kurt R.
Published: March 2023

Supplementary Data from Early Therapy Evaluation of Combined Anti–Death Receptor 5 Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts by Diffusion-Weighted Magnetic Resonance Imaging
Supplementary Figure Legends 1-3, Table Legend 1 from Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
Authors: Prevo Remko , Deutsch Eric , Sampson Oliver , Diplexcito Julie , Cengel Keith , Harper Jane , O'Neill Peter , McKenna W. Gillies , Patel Sonal , Bernhard Eric J.
Published: March 2023

Supplementary Figure Legends 1-3, Table Legend 1 from Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
Supplementary Figure Legends 1-7 from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure Legends 1-7 from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figure 7a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 7a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figure 6b from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 6b from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figures 1-5 and 7 from The SWI/SNF ATPase Brm Is a Gatekeeper of Proliferative Control in Prostate Cancer
Authors: Shen Hui , Powers Nathan , Saini Nitin , Comstock Clay E.S. , Sharma Ankur , Weaver Katherine , Revelo Monica P. , Gerald William , Williams Erin , Jessen Walter J. , Aronow Bruce J. , Rosson Gary , Weissman Bernard , Muchardt Christian , Yaniv Moshe , Knudsen Karen E.
Published: March 2023

Supplementary Figures 1-5 and 7 from The SWI/SNF ATPase Brm Is a Gatekeeper of Proliferative Control in Prostate Cancer
Supplementary Figure 5a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 5a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figure 4a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 4a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Tables 1-3 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Authors: Ding Zhen-Bin , Shi Ying-Hong , Zhou Jian , Qiu Shuang-Jian , Xu Yang , Dai Zhi , Shi Guo-Ming , Wang Xiao-Ying , Ke Ai-Wu , Wu Bin , Fan Jia
Published: March 2023

Supplementary Tables 1-3 from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Supplementary Figure 3b from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 3b from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figure Legend from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Authors: Ding Zhen-Bin , Shi Ying-Hong , Zhou Jian , Qiu Shuang-Jian , Xu Yang , Dai Zhi , Shi Guo-Ming , Wang Xiao-Ying , Ke Ai-Wu , Wu Bin , Fan Jia
Published: March 2023

Supplementary Figure Legend from Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Supplementary Figure 3a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Authors: Shi Jue , Orth James D. , Mitchison Tim
Published: March 2023

Supplementary Figure 3a from Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5
Supplementary Figure Legends 1-4 from Imaging Transgene Activity In vivo
Authors: Gade Terence P.F. , Koutcher Jason A. , Spees William M. , Beattie Bradley J. , Ponomarev Vladimir , Doubrovin Michael , Buchanan Ian M. , Beresten Tatiana , Zakian Kristen L. , Le H. Carl , Tong William P. , Mayer-Kuckuk Philipp , Blasberg Ronald G. , Gelovani Juri G.
Published: March 2023

Supplementary Figure Legends 1-4 from Imaging Transgene Activity In vivo
Supplementary Figure 1 from Dual Function of Pancreatic Endoplasmic Reticulum Kinase in Tumor Cell Growth Arrest and Survival
Authors: Ranganathan Aparna C. , Ojha Shishir , Kourtidis Antonis , Conklin Douglas S. , Aguirre-Ghiso Julio A.
Published: March 2023

Supplementary Figure 1 from Dual Function of Pancreatic Endoplasmic Reticulum Kinase in Tumor Cell Growth Arrest and Survival
Supplementary Figure 3 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Authors: Serra Violeta , Markman Ben , Scaltriti Maurizio , Eichhorn Pieter J.A. , Valero Vanesa , Guzman Marta , Botero Maria Luisa , Llonch Elisabeth , Atzori Francesco , Di Cosimo Serena , Maira Michel , Garcia-Echeverria Carlos , Parra Josep Lluis , Arribas Joaquin , Baselga José
Published: March 2023

Supplementary Figure 3 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Supplementary Figures 2-5 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Authors: Shen Che-Hung , Chen Hsin-Yi , Lin Ming-Shien , Li Fang-Yen , Chang Cheng-Chi , Kuo Min-Liang , Settleman Jeffrey , Chen Ruey-Hwa
Published: March 2023

Supplementary Figures 2-5 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Supplementary Figure 1 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Authors: Serra Violeta , Markman Ben , Scaltriti Maurizio , Eichhorn Pieter J.A. , Valero Vanesa , Guzman Marta , Botero Maria Luisa , Llonch Elisabeth , Atzori Francesco , Di Cosimo Serena , Maira Michel , Garcia-Echeverria Carlos , Parra Josep Lluis , Arribas Joaquin , Baselga José
Published: March 2023

Supplementary Figure 1 from NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
Supplementary Figure Legends 1-12 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Authors: Shen Che-Hung , Chen Hsin-Yi , Lin Ming-Shien , Li Fang-Yen , Chang Cheng-Chi , Kuo Min-Liang , Settleman Jeffrey , Chen Ruey-Hwa
Published: March 2023

Supplementary Figure Legends 1-12 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Supplementary Figure 6 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Authors: Shen Che-Hung , Chen Hsin-Yi , Lin Ming-Shien , Li Fang-Yen , Chang Cheng-Chi , Kuo Min-Liang , Settleman Jeffrey , Chen Ruey-Hwa
Published: March 2023

Supplementary Figure 6 from Breast Tumor Kinase Phosphorylates p190RhoGAP to Regulate Rho and Ras and Promote Breast Carcinoma Growth, Migration, and Invasion
Supplementary Figure 3 from Multimodal Control of Cdc25A by Nitrosative Stress
Authors: Tomko Robert J. , Lazo John S.
Published: March 2023

Supplementary Figure 3 from Multimodal Control of Cdc25A by Nitrosative Stress
Supplementary Table 18 from The Origins of Breast Cancer Prognostic Gene Expression Profiles
Authors: Lukes Luanne , Crawford Nigel P.S. , Walker Renard , Hunter Kent W.
Published: March 2023

Supplementary Table 18 from The Origins of Breast Cancer Prognostic Gene Expression Profiles
Supplementary Table 17 from The Origins of Breast Cancer Prognostic Gene Expression Profiles
Authors: Lukes Luanne , Crawford Nigel P.S. , Walker Renard , Hunter Kent W.
Published: March 2023

Supplementary Table 17 from The Origins of Breast Cancer Prognostic Gene Expression Profiles
Supplementary Table 4 from Salmonella Promoters Preferentially Activated Inside Tumors
Authors: Arrach Nabil , Zhao Ming , Porwollik Steffen , Hoffman Robert M. , McClelland Michael
Published: March 2023

Supplementary Table 4 from Salmonella Promoters Preferentially Activated Inside Tumors
Supplementary Figures 1-2 from Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1α
Authors: Kim Woo-Young , Oh Seung Hyun , Woo Jong-Kyu , Hong Waun Ki , Lee Ho-Young
Published: March 2023

Supplementary Figures 1-2 from Targeting Heat Shock Protein 90 Overrides the Resistance of Lung Cancer Cells by Blocking Radiation-Induced Stabilization of Hypoxia-Inducible Factor-1α